Sign In — Diabetes Care

This item requires a subscription to Diabetes Care.

Original Research - Emerging Treatments & Technologies:

Ralph A. DeFronzo,
Miguel N. Hissa,
Alan J. Garber,
Jorge Luiz Gross,
Raina Yuyan Duan,
Shoba Ravichandran,
Roland S. Chen,
and for the Saxagliptin 014 Study Group

The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone Diabetes Care September 2009 32:1649-1655; published ahead of print May 28, 2009, doi:10.2337/dc08-1984

Pay for Admission - You may access all content in Diabetes Care (from the computer you are currently using) for 30 days for US$45.00.
Regain Access - You can regain access to a recent Pay for Admission purchase if your access period has not yet expired.

This Article

Published online before print May 28, 2009, doi: 10.2337/dc08-1984 Diabetes Care September 2009 vol. 32 no. 9 1649-1655

This Article

Services

Citing Articles

Google Scholar

PubMed

Current Issue

From the Cover